Enhancing the Data Journey in Oncology Clinical Trials
The choices made in clinical trial setup — from patient recruitment strategies to data collection methods — directly impact the success and cost of a trial. Efficiency and data quality are crucial at every point in the drug development process.
The drug development industry has moved from paper-based data collection methods to the use of electronic data capture (EDC) systems over the past two decades. Subsequently, healthcare providers have moved to electronic health records (EHRs). There is significant value in linking these two technologies, and it is predicted that within five years, an EHR-to-EDC system will be a tool most research centers — even smaller trial sites — leverage to streamline and optimize their trial processes.
While EHRs and EDC systems are digital, the connection between them mainly is not digital but analog. This non-digital connection creates an opportunity for innovative approaches using technology to streamline trial processes better, enhancing data accuracy, reducing cost and expediting the development of new therapies. This directly benefits patient safety, trial accessibility, patient engagement and patient recruitment.
Watch this webinar to learn how to avoid any stumbles and how to prepare for and integrate EHR to EDC into your oncology clinical trial operations.
The expert panel is:
- Anthony W. Tolcher, MD, FRCPC, FACP, FASCO, Director of Clinical Research, Founder and CEO of NEXT Oncology
- Andrew Zupnick, PhD, Vice President, Oncology Drug Development, Catalyst Oncology
- Craig McIlloney, Senior Vice President, Catalyst Flex
- Jackie Kent, Executive Industry Advisor
